Acemannan Used as an Implantable Biomaterial for Vital Pulp Therapy of Immature Permanent Teeth Induced Continued Root Formation

Direct pulp-capping, a vital pulp therapy, is used to protect and preserve pulp vitality by applying a biomaterial on the pulp exposure site. Acemannan, a polysaccharide extracted from <i>Aloe vera</i>, induces osteodentin-bridge formation to cover the exposure site in vivo. We evaluated...

Full description

Saved in:
Bibliographic Details
Main Authors: Tien Thuy Vu (Author), Minh Truong Nguyen (Author), Polkit Sangvanich (Author), Quang Ngoc Nguyen (Author), Pasutha Thunyakitpisal (Author)
Format: Book
Published: MDPI AG, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a422a5e75ff4103ae8d40589a727a0c
042 |a dc 
100 1 0 |a Tien Thuy Vu  |e author 
700 1 0 |a Minh Truong Nguyen  |e author 
700 1 0 |a Polkit Sangvanich  |e author 
700 1 0 |a Quang Ngoc Nguyen  |e author 
700 1 0 |a Pasutha Thunyakitpisal  |e author 
245 0 0 |a Acemannan Used as an Implantable Biomaterial for Vital Pulp Therapy of Immature Permanent Teeth Induced Continued Root Formation 
260 |b MDPI AG,   |c 2020-07-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics12070644 
500 |a 1999-4923 
520 |a Direct pulp-capping, a vital pulp therapy, is used to protect and preserve pulp vitality by applying a biomaterial on the pulp exposure site. Acemannan, a polysaccharide extracted from <i>Aloe vera</i>, induces osteodentin-bridge formation to cover the exposure site in vivo. We evaluated the effect of acemannan sponges on partial pulpotomized permanent teeth with caries or accident-induced pulp exposure (<i>n</i> = 50). After removing infected dentin and inflamed pulp tissue, the teeth were randomly divided into acemannan or control (mineral trioxide aggregate (MTA) groups (<i>n</i> = 25). The teeth were examined immediately after treatment (baseline) and at 6- and 12-month follow-ups for clinical and cone beam computed tomography (CBCT) examination. The three-dimensional tooth length and root apex area were simulated to determine treatment success. We found that the overall success rate in the acemannan and MTA groups from baseline to 12-month follow-up was 90.91% and 95.65%, respectively, with no significant difference between the two groups (<i>p</i> > 0.05). In the success teeth in both groups, the <i>root</i> length increased, and the apex area significantly decreased (<i>p</i> < 0.05), indicating continued root formation. Our results suggest that acemannan is a promising low-cost biomaterial for partial pulpotomy treatment for immature permanent teeth requiring vital pulp therapy. 
546 |a EN 
690 |a tissue regeneration 
690 |a acemannan 
690 |a vital pulp therapy 
690 |a biomaterial 
690 |a implantable material 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 7, p 644 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/7/644 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/9a422a5e75ff4103ae8d40589a727a0c  |z Connect to this object online.